Predictive prognostic role of miR-181a with discrepancy in the liver and serum of genotype 4 hepatitis C virus patients

Biomedical Reports

Volumn 2, Issue 6, 2014, Pages 843-848

  Elhelw, Dalia Sherif ^a   Mekky, Radwa Yehia ^a   El Ekiaby, Nada ^a   Ahmed, Rasha ^b   Mohey Eldin, Mohammad Ahmed ^b   El Sayed, Mohammad ^b   Abouelkhair, Mahmoud Mohammad ^b   Salah, Ayman ^c   Zekri, Abdel Rahman ^d   Esmat, Gamal ^b   Abdelaziz, Ahmed Ihab ^a  

^a German University in Cairo GUC   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

Genotype 4; Hepatitis C virus; microRNA 181a; Prognosis; Sustained virological responders; Treatment response

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; LIVER ENZYME; MICRORNA; MICRORNA 181A; PEGINTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CELL COUNTING; CELL VIABILITY; CONTROLLED STUDY; FINE NEEDLE ASPIRATION BIOPSY; GEL ELECTROPHORESIS; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENOTYPING TECHNIQUE; HEPATITIS C; HEPATITIS C VIRUS GENOTYPE 4; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; VIRUS LOAD;

HEPATITIS C VIRUS;

EID: 85010367542     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2014.343     Document Type: Article

References (27)

1. Lima LG, Chammas R, Monteiro RQ, Moreira ME and Barcinski MA: Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 283: 168-175, 2009.
2. Cocucci E, Racchetti G and Meldolesi J: Shedding microvesicles: artefacts no more. Trends Cell Biol 19: 43-51, 2009.
3. Ghosh AK, Secreto CR, Knox TR, Ding W, Mukhopadhyay D and Kay NE: Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 115: 1755-1764, 2010.
4. Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
5. Zhang Q, Pu R, Du Y, Han Y, Su T, Wang H and Cao G: Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets. Cancer Lett 321: 1-12, 2012.
6. Li D, Zhao Y, Liu C, et al: Analysis of miR-195 and miR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722-1730, 2011.
7. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J and Kerin MJ: Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505, 2010.
8. Waters PS, McDermott AM, Wall D, et al: Relationship between circulating and tissue microRNAs in a murine model of breast cancer. PLoS One 7: e50459, 2012.
9. Kutay H, Bai S, Datta J, et al: Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99: 671-678, 2006.
10. Gramantieri L, Ferracin M, Fornari F, et al: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 67: 6092-6099, 2007.
11. Xu J, Wu C, Che X, et al: Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 50: 136-142, 2011.
12. Ji J, Yamashita T, Budhu A, et al: Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 50: 472-480, 2009.
13. Zhan MX, Li Y, Hu BS, et al: Expression of serum microRNAs (miR-222, miR-181, miR-216) in human hepatocellular carcinoma and its clinical significance. Zhonghua Yi Xue Za Zhi 93: 1830-1832, 2013 (In Chinese).
14. Li QJ, Chau J, Ebert PJ, et al: miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161, 2007.
15. Chen CZ, Li L, Lodish HF and Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86, 2004.
16. Liu Y, Zhao JJ, Wang CM, et al: Altered expression profiles of microRNAs in a stable hepatitis B virus-expressing cell line. Chin Med J (Engl) 122: 10-14, 2009.
17. Wald AI, Hoskins EE, Wells SI, Ferris RL and Khan SA: Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33: 504-512, 2011.
18. Liu X, Wang T, Wakita T and Yang W: Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 398: 57-67, 2010.
19. El-Ekiaby, Hamdi N, Negm M, et al: Repressed induction of interferon-related microRNAs miR-146a and miR-155 in peripheral blood mononuclear cells infected with HCV genotype 4. FEBS Open Bio 2: 179-186, 2012.
20. Li YP, Gottwein JM, Scheel TK, Jensen TB and Bukh J: MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR. Proc Natl Acad Sci USA 108: 4991-4996, 2011.
21. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
22. Hu Z, Chen X, Zhao Y, et al: Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 28: 1721-1726, 2010.
23. Köberle V, Waidmann O, Kronenberger B, et al: Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy. J Viral Hepat 20: 530-535, 2013.
24. Su TH, Liu CH, Liu CJ, et al: Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C. Proc Natl Acad Sci USA 110: 7844-7849, 2013.
25. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH and Filipowicz W: Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15: 31-33, 2009.
26. Bala S, Tilahun Y, Taha O, Alao H, Kodys K, Catalano D and Szabo G: Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection. J Transl Med 10: 151, 2012.
27. Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X and Sun S: Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology 56: 1631-1640, 2012.